共 46 条
Controlled silver electrodeposition on gold nanoparticle antibody tags for ultrasensitive prostate specific antigen sensing using electrochemical and optical smartphone detection
被引:3
作者:
Redondo-Fernandez, Guillermo
[1
]
Cid-Barrio, Laura
[1
]
Fernandez-Arguelles, Maria T.
[1
]
de la Escosura-Muniz, Alfredo
[1
]
Soldado, Ana
[1
]
Costa-Fernandez, Jose M.
[1
]
机构:
[1] Univ Oviedo, Dept Phys & Analyt Chem, Ave Julian Claveria 8, Oviedo 33006, Spain
来源:
关键词:
Immunosensor;
Biomarker;
Nanoparticle size-enhancement;
Smartphone detection;
Prostate specific antigen;
HIGHLY SENSITIVE DETECTION;
IMMUNOSORBENT-ASSAY ELISA;
HUMAN SERUM;
SIGNAL AMPLIFICATION;
6-PHOSPHONOHEXANOIC ACID;
PSA;
IMMUNOSENSOR;
QUANTITATION;
DEPOSITION;
BLOCKING;
D O I:
10.1016/j.talanta.2024.126095
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
One of the current challenges in medicine is to achieve a rapid and unequivocal detection and quantification of extremely low levels of disease biomarkers in complex biological samples. Here, we present the development and analytical evaluation of a low-cost smartphone-based system designed for ultrasensitive detection of the prostate-specific antigen (PSA) using two detection alternatives: electrochemical or optical, by coupling the smartphone with a portable potentiostat or magnifying lenses. An antibody tagged with gold nanoparticles (AuNPs), and indium tin oxide coated polyethylene terephthalate platform (ITO-PET) have been used to develop a sandwich-type immunoassay. Then, a controlled silver electrodeposition on the AuNPs surface is carried out, enhancing their size greatly. Due to such strong nanoparticle-size amplification (from nm to mu m), the final detection can be dual, by measuring current intensity or the number of silver-enlarged microstructures generated. The proposed strategies exhibited limit detections (LOD) of 102 and 37 fg/mL for electrochemical and optical detection respectively. The developed immunosensor reaches excellent selectivity and performance characteristics to quantify biomarkers at clinically relevant values without any pretreatment. These proposed procedures could be useful to check and verify possible recurrence after clinical treatment of tumors or even report levels of disease serum biomarkers in early stages.
引用
收藏
页数:10
相关论文